These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18537519)

  • 1. Emerging drugs for idiopathic thrombocytopenic purpura in adults.
    Li X; Hou M
    Expert Opin Emerg Drugs; 2008 Jun; 13(2):237-54. PubMed ID: 18537519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.
    Imbach P
    Paediatr Drugs; 2003; 5(12):795-801. PubMed ID: 14658921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura.
    Palaniappan G; Jennings W
    Mo Med; 2009; 106(1):69-73. PubMed ID: 19245128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immune thrombocytopenic purpura in adults.
    Bussel J
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-37 reduces inflammation and impairs phagocytosis of platelets in immune thrombocytopenia (ITP).
    Zhao Y; Ni X; Xu P; Liu Q; Sun T; Liu X; Ji X; Qiu J; Li J; Wang S; Han P; Peng J; Hou M; Li G
    Cytokine; 2020 Jan; 125():154853. PubMed ID: 31557634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab treatment for chronic refractory idiopathic thrombocytopenic purpura.
    Zhou Z; Yang R
    Crit Rev Oncol Hematol; 2008 Jan; 65(1):21-31. PubMed ID: 17681784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D
    Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults.
    George JN; Raskob GE
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):5-8. PubMed ID: 9523743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for immune thrombocytopenia (ITP).
    Salama A
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):27-38. PubMed ID: 28253829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic idiopathic thrombocytopenic purpura: present strategy, guidelines and new insights.
    Stevens W; Koene H; Zwaginga JJ; Vreugdenhil G
    Neth J Med; 2006 Nov; 64(10):356-63. PubMed ID: 17122451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine idiopathic thrombocytopenic purpura.
    Lewis DC; Meyers KM
    J Vet Intern Med; 1996; 10(4):207-18. PubMed ID: 8819045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of immune thrombocytopenic purpura in adults.
    Stasi R; Provan D
    Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihuman CD44 antibody BJ18 inhibits platelet phagocytosis by correcting aberrant FcɣR expression and M1 polarization in immune thrombocytopenia.
    Sun L; Li L; Sun T; Zhang L; Li C; Xu M; Hou Y; Peng J; Hou M; Wang L
    Int Immunopharmacol; 2021 Jun; 95():107502. PubMed ID: 33690000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
    Liebman HA
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenic purpura of childhood.
    Nugent DJ
    Hematology Am Soc Hematol Educ Program; 2006; ():97-103. PubMed ID: 17124046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model.
    Alves-Rosa F; Stanganelli C; Cabrera J; van Rooijen N; Palermo MS; Isturiz MA
    Blood; 2000 Oct; 96(8):2834-40. PubMed ID: 11023519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab treatment for symptomatic chronic ITP.
    Tamminga RY; Bruin MC
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):714-6. PubMed ID: 16933264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.